Clinical Trial Update: International Study for Treatment of Childhood Relapsed Precursor B-Cell ALL 2020 (IntReALL BCP 2020) [Phase 3]

View source ↗

Summary

A Phase 3 international trial investigating treatment for childhood relapsed precursor B-cell acute lymphoblastic leukemia, with status not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Acute Lymphoblastic Leukemia

Snippet

Sponsor: Charite University, Berlin, Germany | Conditions: B-Cell Acute Lymphoblastic Leukaemia | Phase 3 | Status: NOT_YET_RECRUITING